Multiple recent investigations have shown that signal transducer and activator of transcription (STAT3) is active by default in a variety of malignant tumors and tumor cell lines, including breast cancer, prostate cancer, pancreatic adenocarcinoma, colon carcinoma, and GC [9, 10]. Here, STAT3 is linked to cancer.